Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berkeley International Capital Corporation, operating as Berkeley VC International, is a San Francisco-based venture capital firm specializing in growth-stage investments in the technology and life sciences sectors. Founded in 1982 by Arthur Trueger, the firm provides private placement capital typically ranging from $1 million to $50 million for companies approaching product launch and commercialization. Its investment mandate is broad, encompassing biotechnology, healthcare, medical equipment, semiconductors, and software. The firm is recognized for its 'patient capital' approach, offering strategic guidance and operational mentorship to help high-growth companies navigate the transition from development to market leadership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berkeley International Capital.